Resolution of insulin-requiring diabetes after cessation of chemotherapy for tuberculosis

Journal of the Royal Society of Medicine

Volumn 98, Issue 6, 2005, Pages 270-271

  Waterhouse, Mona ^a   Wilson, Claire ^a   White, Veronica L C ^a   Chowdhury, Tahseen A ^a  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; INSULIN; ISONIAZID; ISONIAZID PLUS RIFAMPICIN; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIABETES MELLITUS; EYE TOXICITY; FEMALE; HUMAN; HUMAN TISSUE; LABORATORY TEST; TUBERCULOSIS; CHEMICALLY INDUCED DISORDER; DRUG COMBINATION; INSULIN DEPENDENT DIABETES MELLITUS; RISK FACTOR; TUBERCULOUS LYMPHADENITIS;

ADULT; ANTITUBERCULAR AGENTS; DIABETES MELLITUS, TYPE 1; DRUG COMBINATIONS; FEMALE; HUMANS; RISK FACTORS; TUBERCULOSIS, LYMPH NODE;

EID: 20644468802     PISSN: 01410768     EISSN: None     Source Type: Journal    
DOI: 10.1258/jrsm.98.6.270     Document Type: Article

References (10)

1. Chan JC, Cockram CS, Critchley JA. Drug-induced disorders of glucose metabolism. Mechanisms and management. Drug Saf 1996;15:135-57
2. Kane JM, Barrett EJ, Casey DE, et al. Metabolic effects of treatment with atypical antipsychotics. J Clin Psychiatry 2004;65:1447-55
3. Woerle HJ, Mariuz PR, Meyer C, et al. Mechanisms for the deterioration in glucose tolerance associated with HIV protease inhibitor regimens. Diabetes 2003;52:918-25
4. Basoglu OK, Bacakoglu F, Cok G, Sayiner A, Ates M. The oral glucose tolerance test in patients with respiratory infections. Monaldi Arch Chest Dis 1999;54:307-10
5. Ismail Y. Pulmonary tuberculosis-a review of clinical features and diagnosis in 232 cases. Med J Malaysia 2004;59:56-64
6. Ponce-De-Leon A, Garcia-Garcia Md Mde L, Garcia-Sancho MC, et al. Tuberculosis and diabetes in southern Mexico. Diab Care 2004;27:1584-90
7. Kihara Y, Otsuki M. Interaction of gliclazide and rifampicin. Diab Care 2000;23:1204-5
8. Self TH, Tsui SJ, Fowler JW. Interaction of rifampin and glyburide. Chest 1989;96:1443-4
9. Atkin SL, Masson EA, Bodmer CW, Walker BA, White MC. Increased insulin requirement in a patient with type 1 diabetes treated with rifampicin. Diab Med 1993;10:392
10. Takasu N, Yamada T, Miura H, et al. Rifampicin-induced early phase hyperglycemia in humans. Am Rev Respir Dis 1982;125:23-7